BioCentury | Aug 4, 2017
Financial News

Follow-on Roundup: Actinium, Kamada, Tetraphase

...company submitted to FDA a proposed Phase III protocol for its inhaled alpha-1 antitrypsin ( AAT-IH...
...NASDAQ:KMDA), Ness Ziona, Israel Tetraphase Pharmaceuticals Inc. (NASDAQ:TTPH), Watertown, Mass. Business: Cancer, Endocrine/Metabolic, Infectious Elizabeth S. Eaton BC8 inhaled alpha-1 antitrypsin (AAT) Iomab-B TP-434 Actinium...
BioCentury | Jul 28, 2017
Financial News

Follow-on roundup: Actinium, Kamada, Tetraphase

...company submitted to FDA a proposed Phase III protocol for its inhaled alpha-1 antitrypsin ( AAT-IH...
BioCentury | Jun 22, 2017
Clinical News

Kamada withdraws MAA for inhaled ATT

...Kamada Ltd. (Tel Aviv:KMDA; NASDAQ:KMDA) said it withdrew its MAA for inhaled alpha-1 antitrypsin (AAT-IH, aerosolized...
...Aviv:KMDA; NASDAQ:KMDA), Ness Ziona, Israel Product: Inhaled alpha-1 antitrypsin (AAT-IH) (aerosolized alpha-1 antitrypsin) Business: Endocrine/Metabolic Chris Lieu AAT-IH inhaled alpha-1 antitrypsin (AAT) Chiesi...
BioCentury | Jun 22, 2017
Company News

Kamada withdraws MAA for inhaled AAT

...of AAT. Its inhaled formulation uses the eFlow Nebulizer System from Pari GmbH (Starnberg, Germany). Chris Lieu inhaled alpha-1 antitrypsin (AAT) Kamada...
BioCentury | Sep 5, 2016
Clinical News

Inhaled alpha-1 antitrypsin: Phase II data

...Ness Ziona, Israel Pari GmbH , Starnberg, Germany Product: Inhaled alpha-1 antitrypsin (AAT) , Aerosolized Alpha-1 antitrypsin ( AAT-IH...
BioCentury | Aug 30, 2016
Clinical News

Kamada's inhaled AAT meets in U.S. Phase II

Kamada Ltd. (Tel Aviv:KMDA; NASDAQ:KMDA) advanced $0.36 to $4.89 on NASDAQ on Tuesday after its inhaled alpha-1 antitrypsin ( AAT ; A1AT ; SERPINA1 ) met the primary endpoint in a 36-patient U.S. Phase II study to...
BioCentury | Apr 4, 2016
Clinical News

Inhaled alpha-1 antitrypsin regulatory update

...EMA accepted for review an MAA from Kamada for inhaled alpha-1 antitrypsin (AAT) to treat AAT deficiency. The MAA...
...Ziona, Israel Pari GmbH , Starnberg, Germany Product: Inhaled alpha-1 antitrypsin (AAT) , Aerosolized Alpha-1 antitrypsin (AAT) ( AAT-IH...
BioCentury | Dec 21, 2015
Clinical News

Aerosolized Alpha-1 antitrypsin: Completed Phase II enrollment

...NASDAQ:KMDA), Ness Ziona, Israel Pari GmbH , Starnberg, Germany Product: Aerosolized Alpha-1 antitrypsin (AAT) ( AAT-IH...
BioCentury | Sep 8, 2014
Clinical News

Aerosolized Alpha-1 antitrypsin: Phase II/III final data

...function differences, but could not be reached for details. Product: Aerosolized Alpha-1 antitrypsin (AAT) ( AAT-IH...
BioCentury | May 19, 2014
Clinical News

Aerosolized Alpha-1 antitrypsin: Phase II/III data

...NASDAQ:KMDA), Ness Ziona, Israel Pari GmbH , Starnberg, Germany Product: Aerosolized Alpha-1 antitrypsin (AAT) ( AAT-IH...
Items per page:
1 - 10 of 20